Sign in

CIK 0001817713 · Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822289112
Phone
(858) 751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. SC 13D Stake Beneficial Ownership Report
  4. 8-K Event Bylaws or fiscal year change · Other events
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. 424B4 Offering Prospectus
  10. EFFECT Other Notice of Effectiveness
  11. S-1MEF Other S-1MEF
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 21 of 23 · 442 filings